USD
+$0.00
(+0.00%
)At Close (As of Sep 5, 2025)
$713.47M
Market Cap
-
P/E Ratio
-2.25
EPS
$21.40
52 Week High
$5.41
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $53M |
Total Revenue | $54M |
Cost Of Revenue | $848K |
Costof Goods And Services Sold | $848K |
Operating Income | -$193M |
Selling General And Administrative | $77M |
Research And Development | $170M |
Operating Expenses | $247M |
Investment Income Net | - |
Net Interest Income | $21M |
Interest Income | $23M |
Interest Expense | $1.6M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $848K |
Income Before Tax | -$172M |
Income Tax Expense | $2M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$174M |
Comprehensive Income Net Of Tax | - |
Ebit | -$170M |
Ebitda | -$169M |
Net Income | -$174M |
Field | Value (USD) |
---|---|
Total Assets | $760M |
Total Current Assets | $745M |
Cash And Cash Equivalents At Carrying Value | $224M |
Cash And Short Term Investments | $224M |
Inventory | - |
Current Net Receivables | $6.1M |
Total Non Current Assets | $15M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | $503M |
Other Current Assets | $11M |
Other Non Current Assets | - |
Total Liabilities | $347M |
Total Current Liabilities | $79M |
Current Accounts Payable | $1.5M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $6.4M |
Total Non Current Liabilities | $268M |
Capital Lease Obligations | $7.1M |
Long Term Debt | $6.9M |
Current Long Term Debt | $2.6M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $17M |
Other Current Liabilities | $69M |
Other Non Current Liabilities | $1.8M |
Total Shareholder Equity | $414M |
Treasury Stock | - |
Retained Earnings | -$895M |
Common Stock | $8K |
Common Stock Shares Outstanding | $86M |
Field | Value (USD) |
---|---|
Operating Cashflow | $134M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $848K |
Capital Expenditures | $472K |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | -$102M |
Cashflow From Financing | $154M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$174M |
Field | Value (USD) |
---|---|
Gross Profit | $53M |
Total Revenue | $54M |
Cost Of Revenue | $848K |
Costof Goods And Services Sold | $848K |
Operating Income | -$193M |
Selling General And Administrative | $77M |
Research And Development | $170M |
Operating Expenses | $247M |
Investment Income Net | - |
Net Interest Income | $21M |
Interest Income | $23M |
Interest Expense | $1.6M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $848K |
Income Before Tax | -$172M |
Income Tax Expense | $2M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$174M |
Comprehensive Income Net Of Tax | - |
Ebit | -$170M |
Ebitda | -$169M |
Net Income | -$174M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops drugs for the treatment of cancer in the United States. The company is headquartered in San Diego, California.